Multi-therapeutic methodologies have attracted considerable attention toward cancer therapy, which can overcome the limitation of a single therapy and achieve an optimized anticancer efficacy. Herein, we prepared a systematic anticancer drug by intercalating zinc phthalocyanines (ZnPc) into a layered double hydroxide (LDH) gallery, followed by loading doxorubicin (DOX) on the surface (denoted as ZnPc-DOX/LDH). ZnPc is accommodated in the interlayer region of the LDH, which results in a largely enhanced photodynamic therapeutic (PDT) efficiency; while the physisorbed DOX affords a chemotherapeutic effect. In vitro tests performed with KB cells indicate a synergistic anticancer performance as well as excellent biocompatibility compared with pristine ZnPc and DOX. This study demonstrates a promising bio-composite for PDT-chemotherapy systematic therapy, which shows potential application in the field of cancer therapy.
No takes yet. Share an insight, caveat, or question.
Mei et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: